Also, Sun T et al. [262] uncovered the oncogenic potential of LINC00942 (LNC942) and METTL14, which upregulated the expression and stability of two downstream target genes CXCR4 and CYP1B1 by promoting METTL14-mediated m6A methylation that subsequently led to accelerating BC cell proliferation, colony formation, and reduced BC cell apoptosis in vitro and in vivo. The gene discussed is METTL14; the disease is breast cancer.